Dinesh Thakur, former Ranbaxy director and global head of research information & portfolio management, is entitled to $48.6 million (Rs 266 crore with respect to $1=Rs 54.80) as the whistleblower in the case, the U.S. Justice Department said. It was Thakur who uncovered the unsafe practices and violations at Ranbaxy. (Read the full story here)
"Ranbaxy's management was notified of these widespread problems. When they failed to correct the problems, it left me with no choice but to alert healthcare authorities," Thakur said in a statement.
"It took us eight years to help government authorities unravel a complicated trail of falsified records and dangerous manufacturing practices that threatened to compromise the quality and safety of Ranbaxy drugs," he added.
(With inputs from Reuters)